Investigating the effect of local, oral and intravenous tranexamic acid on the amount of bleeding during humerus fracture surgery
Phase 3
Recruiting
- Conditions
- Humerus fracture.Age-related osteoporosis with current pathological fracture, humerusM80.02
- Registration Number
- IRCT20141209020258N184
- Lead Sponsor
- Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
All patients with ASA class 1 and 2
All patients with humerus fracture
All patients candidates for elective surgery
18 to 70 years
Patients with BMI greater than 30
Patients candidate for general anesthesia
Exclusion Criteria
Pregnancy
Underlying kidney, heart, lung, and liver disease
Sensitivity to tranexamic acid
No consent to participate in the study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Bleeding. Timepoint: During the operation, recovery and 24 and 48 hours after the operation. Method of measurement: Physical examination.
- Secondary Outcome Measures
Name Time Method